Trinity Delta Lighthouse: Avacta

Trinity Delta view: Avacta’s acquisition of Coris is another step on the pathway to create a full spectrum Diagnostics business that has sufficient product mass and geographic reach to become self-sustaining, both in terms of profitability and new application development. This second deal, following on the heels of Launch Diagnostics in October 2022, provides further momentum to the ‘buy and build’ strategy. While progress in Avacta’s Therapeutics business means it remains in the spotlight, we c

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: AUTO, PNN, DOCS, MEGP, CPI, AVCT, TEAM, & UOG.

Avacta: Building on Therapeutic and Diagnostic foundations

Avacta’s two proprietary platforms, Affimer proteins and pre|CISION, are central to its plans to create novel diagnostic and therapeutic products. Recent operational and strategic developments during 2022 lay the foundations for unlocking value from its Therapeutics and Diagnostics divisions. Further data from lead asset AVA6000 should confirm the clinical utility of pre|CISION, with a wider portfolio being readied to exploit the platform’s tumour-specific activation. An M&A-led growth strategy,

Trinity Delta Lighthouse: Avacta

Trinity Delta view: FY22 results reveal the financial, operational, and strategic progress made across both Avacta’s Therapeutics and Diagnostics divisions. The pre|CISION platform underpins the near- and medium-term prospects of its Therapeutics business, with emerging data from lead asset AVA6000 effectively validating the pre|CISION platform’s tumour targeting potential and providing the blueprint for an extensive pipeline of related products. AVA3996, the second pre|CISION asset, could enter

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: AAL, OCDO, TPK, QLT, HICL, & AVCT.

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: GSK WG., ASHM, DXRX, BOOM, AVCT, TEK, UOG, & EBQ.

Hybridan Small Cap Feast - 06 Apr 23

6 April 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective

Hybridan Small Cap Feast - 05 Apr 23

5 April 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: HSBC, AGR, AVCT, SMD, DXRX, CYAN, TRST, & KAV.

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: AAL, BAE, RR., WPP, GNS, UKW, HIK, HWDN, MGNS, AVCT, RQIH, & TRR.

Hot Off The Wires - The Day Ahead

Today's news and views, plus announcements from: BHMG, DGI9, SUPR, AVCT, KAPE, FRP, & BRCK.

Initial Equity Trading Comments - 15 May 2023

Hybridan Small Cap Feast - 23 Feb 23

23rd May 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv

SP Angel Spec Sits: Not Just a BRICK Company (LVCG LN)

LVCG has evolved to include four primary operating divisions that own and licence a network of live event brands to third parties for concerts, festivals, and events around the world. Based on these diversified revenue streams, we have developed baseline forecasts for LVCG for 2022E and onwards. Our revenue forecasts include assumptions for agreed events, license fees and ticket sales.

In the Flow

Industry flows - bond funds remain preferred over equities Risk appetite for equity funds remained subdued with last week seeing $4bn net outflows (negative in 8 of the last 9 weeks). Flows worsened sequentially for Asia/EM categories, but improved for US and European equities. Bond funds saw inflows for a 10th straight week (c.$8bn) with broad based inflows across US government, IG and HY funds. Listed asset managers flows - inflows into ETFs, outflows from mutual funds ETFs net inflows contin

Preferred Gen AI play

Relx has a 30+ year history benefiting from AI. We think Generative AI is likely to contribute to higher levels of growth and margin expansion. Recent share price weakness offers a buying opportunity in our preferred Gen AI play in Media. Relx - our preferred Gen AI play within Media We review the implications of Gen AI on professional information vendors and argue that Relx is well positioned to benefit. We raise our TP to GBP30 and see Relx as our preferred Gen AI play in European Media. See

GenAI: How to Use It

You''ve been here before, right? Blockchain, the Metaverse - and now GenAI. Could this time really be different and the hype justified? The answer to this question is rooted in how GenAI can be used in the real world. In this report we thus challenge our sector teams to identify GenAI use-cases within their industries - and those companies likely to pioneer them. The result is perhaps the broadest consideration yet of how GenAI can diffuse through the economy. Efficiency is the common theme, pr

Morning Note – 31 May 2023

DWF Group (DWF LN) - Growth accelerating, costs controlled

FY23E performance confirmed as broadly in line with forecasts. Revenue of £380m is +c.8.5% YOY, with H2 growth accelerating to +13.5% (FY23: +3.4%).

Inspired+ (INSE, House Stock, 12.25p) - Variation to Ignite contingent consideration

Hybridan Small Cap Feast - 22 Feb 23

22 February 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objec

Luxury EDGE: global brand heat in April 2023

Brand momentum and popularity is key to both long- and short-term performance. Luxury EDGE distils the latest trends on social media and search engines for up-to-the-minute views on brand heat. What''s new on Luxury EDGE Strong momentum at Cartier, Bulgari, Dior, Hugo Boss, Cucinelli and Tod''s. Key highlights of April were the significant amounts of pop-up stores opening and exhibitions in China. WeChat: Dior, Hugo Boss and Bulgari increased their popularity the most Brands that increased their

More gain than pain from GenAI

The value of Credit Bureau''s proprietary data will likely grow as Generative AI expands. This will support incremental revenue growth with new product innovation partly funded from savings in product development and client service. Risks are moderated by the regulatory environment, embedded processes and concerns that GenAI could see undesired bias creep into the system. We raise CY24-25 organic by ~1% and long-term growth rates by 0.5%. Our preferred plays within the space remain Experian and

Auctus on Friday - 21/04/2023

AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C: Target price of A$0.100 per share: Competent person report confirms the materiality of the Welchau pospect – The Welchau prospect has been estimated to hold between 365 bcfe and 1,128 bcfe of prospective resources by Gaffney, Cline & Associates (GCA) with a mid-case at 645 bcfe including 10.1 mmbbl of condensate. While this is below the 807 bcfe mid-case estimated by ADX, the fact that the lower end of the GCA ran

Hybridan Small Cap Feast - 23 Mar 23

23 March 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv

FY23 Trading Update: Cash outperforms

Eckoh has provided a strong FY’Mar23 trading update which highlights the significant progress made in North America with N. American Security Solutions exit ARR up 34% organically to $15.9m (FY22: $11.9m). Group Revenues were broadly in-line with our forecasts (£39m vs £40m) but adjusted operating margin outperformed by c.50bps at 19.5%. Net Cash also surprised to the upside at £5.7m (vs SCMe: £5.4m). Looking forward, total contracted business grew >50% which alongside the launch of new products